社论。

IF 2.4 4区 医学 Q3 MEDICINE, RESEARCH & EXPERIMENTAL Atla-Alternatives To Laboratory Animals Pub Date : 2023-05-01 DOI:10.1177/02611929231175315
{"title":"社论。","authors":"","doi":"10.1177/02611929231175315","DOIUrl":null,"url":null,"abstract":"Changes to cosmetics regulations internationally have been instrumental in the move away from animal testing and toward the development and promotion of alternative methods. Brazil is one of the largest markets for personal care and cosmetics products in the world and on 1st March 2023, as Resolution No. 58/2023 came into force, Brazil joined over 40 countries moving towards a global ban on the testing of cosmetic ingredients on animals. It is encouraging to witness not only the ongoing progress in governmental policies in mandating alternatives to animals, but also the continual innovations in the associated science. Whilst, currently, there is significant focus on applications in cosmetics, success in this arena will undoubtedly drive forward the use and acceptance of alternatives in other areas. Further details on the Brazilian Resolution are given in the Spotlight on Three Rs Progress section of this issue. This section also includes summaries of different studies that are applying a diverse range of alternative methods, from bioprinting of reconstructed human epidermis for assessing skin irritation, to open-source software that can quantify animal behaviours. Studies on the effects of SARSCoV-2 on the developing fetal brain and a model for human ovarian follicles are also highlighted. The review article by da Silva and Valadares also focuses attention on SARS-CoV-2 and how the pandemic highlighted the need for improvements in non-animal based methods in preclinical research for respiratory diseases. Here, the authors provide a detailed review of key methods that can be applied in this area, including: monolayer cell cultures; air–liquid interface models; lung organoids; human precision-cut lung slices (PCLS); and lung-on-a-chip microfluidic systems. The advantages and limitations of each method are discussed, as well as the need for standardisation and quality control procedures to make these New Approach Methodologies (NAMs) more acceptable for regulatory purposes. The importance of selecting the most appropriate models and endpoints to measure, depending on the research question, is emphasised. Andersson et al. also propose an addition to what they describe as the “NAM-based predictive toolbox”. These authors report an in silicomethod that can be used to differentiate liquids with the potential for eliciting eye irritation, from those considered to be non-irritant. The authors describe a two-tier approach that identifies potential irritants by using predicted pKa values and also by using a model that is derived from Hansen Solubility Parameters. The model performed well, and in order to err on the side of caution, it has been optimised to give a low rate of false negative predictions. The last two articles in this issue both present results from assays for toxicity testing. Hautenen et al. present the results of a study to develop an assay to assess the induction of vasculature formation — a mechanism associated with non-genotoxic carcinogenicity. The coculturing of human umbilical vessel endothelial cells (HUVECs) with human adipose stromal cells (hASCs) has previously been shown to lead to more mature vessel formation, and this system was used as the basis for this study. The authors adapted their standardised vasculogenesis/angiogenesis model (VAM), previously used to detect inhibition of vascular formation, to instead measure induction of vasculature formation. Four new assay protocols were developed and compared, in order to determine the optimum conditions for an assay that can be used to assess the ability of chemicals to induce vasculature formation; this may be indicative of carcinogenesis. Kuruppuarachchi et al. used established assays, based on growth and the evaluation of mitotic indices and chromosomal aberration, for Allium cepa (onion) root tip, to assess potential cytotoxicity and genotoxicity of marine sponge extracts. For many years, extracts from marine sponges have been the subject of investigation due to their potential antibacterial, antiviral, antifungal, antimalarial or anticancer effects. The experiments reported here, showed that both cytotoxicity and genotoxicity were induced in the root tips by the extracts. Root growth was inhibited, mitodepressive effects were induced at all stages of cell division and chromosomal aberrations were also detected. These results indicate that the marine sponge investigated, Luffariella herdmani, may possess antiproliferative activity. This is worthy of further investigation, as there is increasing interest in the development of novel therapeutic agents derived from marine sponges. Finally, readers are directed to a range of information sources and freely available training materials that are signposted in the regular Resources Round-up section; we trust that you will find these useful.","PeriodicalId":55577,"journal":{"name":"Atla-Alternatives To Laboratory Animals","volume":null,"pages":null},"PeriodicalIF":2.4000,"publicationDate":"2023-05-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"Editorial.\",\"authors\":\"\",\"doi\":\"10.1177/02611929231175315\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"Changes to cosmetics regulations internationally have been instrumental in the move away from animal testing and toward the development and promotion of alternative methods. Brazil is one of the largest markets for personal care and cosmetics products in the world and on 1st March 2023, as Resolution No. 58/2023 came into force, Brazil joined over 40 countries moving towards a global ban on the testing of cosmetic ingredients on animals. It is encouraging to witness not only the ongoing progress in governmental policies in mandating alternatives to animals, but also the continual innovations in the associated science. Whilst, currently, there is significant focus on applications in cosmetics, success in this arena will undoubtedly drive forward the use and acceptance of alternatives in other areas. Further details on the Brazilian Resolution are given in the Spotlight on Three Rs Progress section of this issue. This section also includes summaries of different studies that are applying a diverse range of alternative methods, from bioprinting of reconstructed human epidermis for assessing skin irritation, to open-source software that can quantify animal behaviours. Studies on the effects of SARSCoV-2 on the developing fetal brain and a model for human ovarian follicles are also highlighted. The review article by da Silva and Valadares also focuses attention on SARS-CoV-2 and how the pandemic highlighted the need for improvements in non-animal based methods in preclinical research for respiratory diseases. Here, the authors provide a detailed review of key methods that can be applied in this area, including: monolayer cell cultures; air–liquid interface models; lung organoids; human precision-cut lung slices (PCLS); and lung-on-a-chip microfluidic systems. The advantages and limitations of each method are discussed, as well as the need for standardisation and quality control procedures to make these New Approach Methodologies (NAMs) more acceptable for regulatory purposes. The importance of selecting the most appropriate models and endpoints to measure, depending on the research question, is emphasised. Andersson et al. also propose an addition to what they describe as the “NAM-based predictive toolbox”. These authors report an in silicomethod that can be used to differentiate liquids with the potential for eliciting eye irritation, from those considered to be non-irritant. The authors describe a two-tier approach that identifies potential irritants by using predicted pKa values and also by using a model that is derived from Hansen Solubility Parameters. The model performed well, and in order to err on the side of caution, it has been optimised to give a low rate of false negative predictions. The last two articles in this issue both present results from assays for toxicity testing. Hautenen et al. present the results of a study to develop an assay to assess the induction of vasculature formation — a mechanism associated with non-genotoxic carcinogenicity. The coculturing of human umbilical vessel endothelial cells (HUVECs) with human adipose stromal cells (hASCs) has previously been shown to lead to more mature vessel formation, and this system was used as the basis for this study. The authors adapted their standardised vasculogenesis/angiogenesis model (VAM), previously used to detect inhibition of vascular formation, to instead measure induction of vasculature formation. Four new assay protocols were developed and compared, in order to determine the optimum conditions for an assay that can be used to assess the ability of chemicals to induce vasculature formation; this may be indicative of carcinogenesis. Kuruppuarachchi et al. used established assays, based on growth and the evaluation of mitotic indices and chromosomal aberration, for Allium cepa (onion) root tip, to assess potential cytotoxicity and genotoxicity of marine sponge extracts. For many years, extracts from marine sponges have been the subject of investigation due to their potential antibacterial, antiviral, antifungal, antimalarial or anticancer effects. The experiments reported here, showed that both cytotoxicity and genotoxicity were induced in the root tips by the extracts. Root growth was inhibited, mitodepressive effects were induced at all stages of cell division and chromosomal aberrations were also detected. These results indicate that the marine sponge investigated, Luffariella herdmani, may possess antiproliferative activity. This is worthy of further investigation, as there is increasing interest in the development of novel therapeutic agents derived from marine sponges. Finally, readers are directed to a range of information sources and freely available training materials that are signposted in the regular Resources Round-up section; we trust that you will find these useful.\",\"PeriodicalId\":55577,\"journal\":{\"name\":\"Atla-Alternatives To Laboratory Animals\",\"volume\":null,\"pages\":null},\"PeriodicalIF\":2.4000,\"publicationDate\":\"2023-05-01\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Atla-Alternatives To Laboratory Animals\",\"FirstCategoryId\":\"3\",\"ListUrlMain\":\"https://doi.org/10.1177/02611929231175315\",\"RegionNum\":4,\"RegionCategory\":\"医学\",\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"Q3\",\"JCRName\":\"MEDICINE, RESEARCH & EXPERIMENTAL\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Atla-Alternatives To Laboratory Animals","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1177/02611929231175315","RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q3","JCRName":"MEDICINE, RESEARCH & EXPERIMENTAL","Score":null,"Total":0}
引用次数: 0
查看原文
分享 分享
微信好友 朋友圈 QQ好友 复制链接
本刊更多论文
Editorial.
Changes to cosmetics regulations internationally have been instrumental in the move away from animal testing and toward the development and promotion of alternative methods. Brazil is one of the largest markets for personal care and cosmetics products in the world and on 1st March 2023, as Resolution No. 58/2023 came into force, Brazil joined over 40 countries moving towards a global ban on the testing of cosmetic ingredients on animals. It is encouraging to witness not only the ongoing progress in governmental policies in mandating alternatives to animals, but also the continual innovations in the associated science. Whilst, currently, there is significant focus on applications in cosmetics, success in this arena will undoubtedly drive forward the use and acceptance of alternatives in other areas. Further details on the Brazilian Resolution are given in the Spotlight on Three Rs Progress section of this issue. This section also includes summaries of different studies that are applying a diverse range of alternative methods, from bioprinting of reconstructed human epidermis for assessing skin irritation, to open-source software that can quantify animal behaviours. Studies on the effects of SARSCoV-2 on the developing fetal brain and a model for human ovarian follicles are also highlighted. The review article by da Silva and Valadares also focuses attention on SARS-CoV-2 and how the pandemic highlighted the need for improvements in non-animal based methods in preclinical research for respiratory diseases. Here, the authors provide a detailed review of key methods that can be applied in this area, including: monolayer cell cultures; air–liquid interface models; lung organoids; human precision-cut lung slices (PCLS); and lung-on-a-chip microfluidic systems. The advantages and limitations of each method are discussed, as well as the need for standardisation and quality control procedures to make these New Approach Methodologies (NAMs) more acceptable for regulatory purposes. The importance of selecting the most appropriate models and endpoints to measure, depending on the research question, is emphasised. Andersson et al. also propose an addition to what they describe as the “NAM-based predictive toolbox”. These authors report an in silicomethod that can be used to differentiate liquids with the potential for eliciting eye irritation, from those considered to be non-irritant. The authors describe a two-tier approach that identifies potential irritants by using predicted pKa values and also by using a model that is derived from Hansen Solubility Parameters. The model performed well, and in order to err on the side of caution, it has been optimised to give a low rate of false negative predictions. The last two articles in this issue both present results from assays for toxicity testing. Hautenen et al. present the results of a study to develop an assay to assess the induction of vasculature formation — a mechanism associated with non-genotoxic carcinogenicity. The coculturing of human umbilical vessel endothelial cells (HUVECs) with human adipose stromal cells (hASCs) has previously been shown to lead to more mature vessel formation, and this system was used as the basis for this study. The authors adapted their standardised vasculogenesis/angiogenesis model (VAM), previously used to detect inhibition of vascular formation, to instead measure induction of vasculature formation. Four new assay protocols were developed and compared, in order to determine the optimum conditions for an assay that can be used to assess the ability of chemicals to induce vasculature formation; this may be indicative of carcinogenesis. Kuruppuarachchi et al. used established assays, based on growth and the evaluation of mitotic indices and chromosomal aberration, for Allium cepa (onion) root tip, to assess potential cytotoxicity and genotoxicity of marine sponge extracts. For many years, extracts from marine sponges have been the subject of investigation due to their potential antibacterial, antiviral, antifungal, antimalarial or anticancer effects. The experiments reported here, showed that both cytotoxicity and genotoxicity were induced in the root tips by the extracts. Root growth was inhibited, mitodepressive effects were induced at all stages of cell division and chromosomal aberrations were also detected. These results indicate that the marine sponge investigated, Luffariella herdmani, may possess antiproliferative activity. This is worthy of further investigation, as there is increasing interest in the development of novel therapeutic agents derived from marine sponges. Finally, readers are directed to a range of information sources and freely available training materials that are signposted in the regular Resources Round-up section; we trust that you will find these useful.
求助全文
通过发布文献求助,成功后即可免费获取论文全文。 去求助
来源期刊
CiteScore
3.80
自引率
3.70%
发文量
60
审稿时长
>18 weeks
期刊介绍: Alternatives to Laboratory Animals (ATLA) is a peer-reviewed journal, intended to cover all aspects of the development, validation, implementation and use of alternatives to laboratory animals in biomedical research and toxicity testing. In addition to the replacement of animals, it also covers work that aims to reduce the number of animals used and refine the in vivo experiments that are still carried out.
期刊最新文献
Introducing the COST Action 'Improving the Quality of Biomedical Science with 3Rs Concepts' (IMPROVE). Journeying Through Journals: The Publishing Process and How to Maximise Research Impact. Progress and Remaining Opportunities to Increase the Use of Animal-free Antibodies in the USA. Editorial. An Evaluation of the Replacement of Animal-derived Biomaterials in Human Primary Cell Culture.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
已复制链接
已复制链接
快去分享给好友吧!
我知道了
×
扫码分享
扫码分享
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1